A Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 09 Apr 2018
At a glance
- Drugs Insulin degludec/liraglutide (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms DUAL VIII
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 03 Mar 2017 Planned End Date changed from 1 Oct 2018 to 3 Oct 2018.
- 03 Mar 2017 Planned primary completion date changed from 1 Oct 2018 to 3 Oct 2018.